Form 4 for IMAX IMAX CORP
Accepted 2025-11-24 00:00:00 ET · period of report 2025-11-24 · accession 0001214659-25-017139 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-11-24 | 2025-11-24 | IMAX | Fernandes Natasha | CFO, EVP | C - Cnv Deriv | $22.49 | +2,652 | 33.9K | +8% | +$59.6K |
| D | 2025-11-24 | 2025-11-24 | IMAX | Fernandes Natasha | CFO, EVP | S - Sale | $36.15 | -2,652 | 31.3K | -8% | -$95.9K |
| D | 2025-11-24 | 2025-11-24 | IMAX | Fernandes Natasha | CFO, EVP | C - Cnv Deriv | $22.49 | -2,652 | 0 | -100% | -$59.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | common shares | 2025-11-24 | C | A | 2,652 | $22.49 | 33,909 | D | — | — | (F1) Represents the conversion upon exercise of stock options into common shares. |
| 2 | Common | common shares | 2025-11-24 | S | D | 2,652 | $36.15 | 31,257 | D | — | — | |
| 3 | Derivative | stock options (to buy) | 2025-11-24 | C | D | 2,652 | $22.49 | 0 | D | $22.49 · — to 2026-03-07 | 2,652 common shares | (F2) These options were issued in 2019 and are set to expire on March 7, 2026. (F4) This represents the number of stock options for this transaction only. Ms. Fernandes' aggregate remaining outstanding restricted share unit and common share balances following these transactions will be 39,734 and 31,257, respectively. (F3) The stock options became exercisable in four installments: 530 on March 7, 2020, 663 on each of March 7, 2021 and March 7, 2022 and 796 on March 7, 2023. |